GT Biopharma GTBP
NASDAQ GTBP
$3.72 -0.12 (-3.12%)
At close: Nov 13, 2026 · 4:00 PM EST

GT Biopharma (GTBP) Interest & Investment Income (2009 - 2026)

Updated

GT Biopharma's Interest & Investment Income was $58,000 in Q2 2026, up 52.6% from $38,000 a year earlier but down 13.4% from the prior quarter.

Analysis

GT Biopharma (GTBP) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, GT Biopharma's Interest & Investment Income was $178,000 through Jun 30, 2026, down 20.9% year-over-year; for FY2025, it was $123,000, down 69.4% from FY2024.

  • Interest & Investment Income shows a four-year compound annual growth rate of 34.1% (FY2021 to FY2025).
  • In earlier years, Interest & Investment Income was $402,000 in FY2024 (-48.5%), $780,000 in FY2023 (+167.1%), $292,000 in FY2022 (+668.4%) and $38,000 in FY2021.
  • Quarterly Interest & Investment Income has moved between -$107,000 (Q3 2022) and $443,000 (Q4 2022) over five years.
  • Compared with a year earlier, Interest & Investment Income was higher in two of the last eight quarters, with an average decline of 29.5%.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q1 2026 (growth of 109.4%); the worst was Q1 2025 (a decline of 77.5%).
  • Per Business Quant data, GTBP's Interest & Investment Income in the three quarters before Q2 2026 was $67,000 (Q1 2026), $17,000 (Q4 2025) and $36,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 186.00 Mn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 67.00 Mn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 GT Biopharma 6.65 Mn -16.58 Mn - 58,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58,000.00
Mar 31, 2026 67,000.00
Dec 31, 2025 17,000.00
Sep 30, 2025 36,000.00
Jun 30, 2025 38,000.00
Mar 31, 2025 32,000.00
Dec 31, 2024 59,000.00
Sep 30, 2024 96,000.00
Jun 30, 2024 105,000.00
Mar 31, 2024 142,000.00
Dec 31, 2023 180,000.00
Sep 30, 2023 216,000.00
Jun 30, 2023 220,000.00
Mar 31, 2023 164,000.00
Dec 31, 2022 443,000.00
Sep 30, 2022 -107,000.00
Jun 30, 2022 -36,000.00
Mar 31, 2022 -8,000.00
Dec 31, 2021 6,000.00
Sep 30, 2021 32,000.00
API Access

GT Biopharma Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=GTBP&period=max&api_key=YOUR_API_KEY